Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma

E Alemao; S Rajagopalan; RE Curiel; J Purvis; SL Yang; Maiwenn Al

doi:10.3111/13696998.2011.566296

Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma

E Alemao, S Rajagopalan, RE Curiel, J Purvis, SL Yang, Maiwenn Al

Health Economics (HE)

Research output: Contribution to journal › Article › Academic

1 Citation (Scopus)

Original language	English
Pages (from-to)	245-252
Number of pages	8
Journal	Journal of Medical Economics
Volume	14
Issue number	2
DOIs	https://doi.org/10.3111/13696998.2011.566296
Publication status	Published - 2011

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

10.3111/13696998.2011.566296

http://hdl.handle.net/1765/25508

Cite this

@article{a969e18f4c104288a51d4013147dc683,

title = "Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma",

author = "E Alemao and S Rajagopalan and RE Curiel and J Purvis and SL Yang and Maiwenn Al",

year = "2011",

doi = "10.3111/13696998.2011.566296",

language = "English",

volume = "14",

pages = "245--252",

journal = "Journal of Medical Economics",

issn = "1369-6998",

publisher = "Taylor & Francis Ltd",

number = "2",

}

TY - JOUR

T1 - Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma

AU - Alemao, E

AU - Rajagopalan, S

AU - Curiel, RE

AU - Purvis, J

AU - Yang, SL

AU - Al, Maiwenn

PY - 2011

Y1 - 2011

U2 - 10.3111/13696998.2011.566296

DO - 10.3111/13696998.2011.566296

M3 - Article

C2 - 21417551

SN - 1369-6998

VL - 14

SP - 245

EP - 252

JO - Journal of Medical Economics

JF - Journal of Medical Economics

IS - 2

ER -